CClinicalTrials.gg
CompletedNCT05449223Updated Jan 17, 2023

Urdu Version of Frenchay Activities Index: Reliability and Validity Study

An observational study in Activity, Motor, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-01-17.

Sponsored by Riphah International University · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
75
Ages
65 Years and older
Sex
All
01

Study summary

In this study, we will observe the reliability and validity of frenchay activities index and barthel index in urdu language in geriatric population of Pakistan.

Read the detailed description

The aim of study is to translate and culturally adapt Frenchay Activities Index and Bathel Index into Urdu language and secondly to investigate the reliability and validity of Frenchay Activities Index and Barthel Index in geriatric population of Pakistan. This study will be cross sectional survey study in which convenience sampling technique will be used.

The results of study will help to know the validity and reliability of Frenchay Activities Index and Barthel Index in Urdu version with Activities of Daily Livings impairments in geriatric population of Pakistan. The reliability of the questionnaire will be checked through internal consistency and test-retest methods. internal consistency will be analyzed with Cronbach's alpha value. Test-retest reliability will be assessed using an intra-class correlation coefficient with 75 patients.

02

Conditions studied

  • Activity, Motor

Keywords

  • Frenchay Activities Index
  • Urdu Version
  • Activities of Daily Living
  • Validity
  • Reliability
03

In context

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Elderly people, especially those of the advanced ages having issue in performing in activities of daily living

Inclusion criteria

  • 65 years old and older
  • be able to read Urdu
  • be living in Pakistan for more than 5 years
  • have minimal cognitive impairment with Mini-Mental State Examination
  • have no significant muscle, joint, or neurologic conditions such as stroke, or Parkinson's disease.

Exclusion criteria

Exclusion Criteria:

  • inability to understand to follow the instructions of Frenchay Activities Index and Barthel Index
  • experience with the Frenchay Activities Index and Bathel Index in the last 6 months
  • acute illness or fracture in the lower extremities
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
75 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Frenchay activities index

    Frenchay Activities Index is used to measure performance in activities of daily living. It contains 15 items on common daily activities such as preparing a meal, washing the dishes, housekeeping, shopping, hobbies, going out, and work. The patient is asked whether or not he/she did the activities for the past 3-6 months. The scores are from 1 (never) to 4 (normal frequency) with a total score range from 15 to 60. A lower score means a lower level of functioning.

    Time frame: 12th Week

  2. Barthel Index

    Barthel Index is used to measure performance in activities of daily living. The Barthel Index contains 10 items on sphincter control, grooming, toilet use, eating, transfer, and mobility compromising one dimension on the need for help. The score differs per item and the total score ranges from 0 (totally dependent) to 20 (independent).

    Time frame: 12th Week

07

Study locations

1 site
  • Riphah International University
    Faisalābad, Punjab 38000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05449223
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Jul 8, 2022
Start date
Mar 30, 2021
Primary completion
Jul 27, 2022
Completion
Jul 28, 2022
Last update
Jan 17, 2023

Study contacts

Muhammed Kashif
study chair · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion